Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tumena Corrah

Showing results (11-20 of 14) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 14 results.
Clinical Medicine (London, England)|July 19, 2020
Experience of a novel community testing programme for COVID-19 in London: Lessons learntGabriel Wallis, Francesca Siracusa, Michael Blank, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Nature Reviews. Drug Discovery|July 18, 2015
Towards host-directed therapies for tuberculosisAlimuddin Zumla, Markus Maeurer, , et al.
Pageof 2

Showing results (11-20 of 14) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 14 results.
Clinical Medicine (London, England)|July 19, 2020
Experience of a novel community testing programme for COVID-19 in London: Lessons learntGabriel Wallis, Francesca Siracusa, Michael Blank, et al.
Plos One|March 21, 2024
COVID-19 in non-hospitalised adults caused by either SARS-CoV-2 sub-variants Omicron BA.1, BA.2, BA.4/5 or Delta associates with similar illness duration, symptom severity and viral kinetics, irrespective of vaccination historyHermaleigh Townsley, Joshua Gahir, Timothy W Russell, et al.
The Lancet. Infectious Diseases|September 14, 2024
Real-time estimation of immunological responses against emerging SARS-CoV-2 variants in the UK: a mathematical modelling studyTimothy W Russell, Hermaleigh Townsley, Joel Hellewell, et al.
Nature Reviews. Drug Discovery|July 18, 2015
Towards host-directed therapies for tuberculosisAlimuddin Zumla, Markus Maeurer, , et al.
Pageof 2